1470408333626679301

Today at @ASH_hematology Annual Meeting & Exposition, we will also share more data on omidubicel, our lead advanced cell therapy candidate for blood cancers, and its impact on hospitalization and healthcare resource use. https://t.co/LoBKZX0jrT

Send us a message